L7 | CHATS

customer story

Building the Future of Cell Therapy: How Cellipont Bioservices Transformed Manufacturing Through Enhanced Quality and Operational Efficiency with a Unifying Platform

by Oana I. Lungu | posted on February 13, 2025

Paper-based processes and disconnected workflows create bottlenecks in cell therapy manufacturing, slowing progress and increasing risks. Manual inefficiencies aren’t just an operational burden; they threaten quality, compliance, and scalability.

How do you move beyond these barriers to a fully digitalized, future-ready manufacturing ecosystem? For Cellipont Bioservices (Cellipont), a leader in cell therapy CDMO services, the answer was clear: embrace a robust and flexible unifying platform. When launching its state-of-the-art manufacturing facility in The Woodlands, TX, Cellipont seized the opportunity to digitally transform its operations with L7|ESP, including its Manufacturing Execution System (MES). By leveraging workflow orchestration and data contextualization, Cellipont didn’t just optimize processes, it set a new standard for efficiency, compliance, and innovation.

“The unifying L7|ESP platform is the ideal solution for us to digitalize, modernize, and improve our internal Excel spreadsheet- and paper-based processes to formalize our manufacturing processes and data and to optimize quality review and inventory management,” said Mike O’Mara, Chief Operating Officer at Cellipont Bioservices. The impact was transformative across the business:

  • Streamlined digital workflows replaced paper-based batch records, increasing efficiency and accuracy.
  • Efficient QA processes accelerated quality reviews while keeping manufacturing activities aligned.
  • Automated sample tracking reduced errors and freed up valuable time.
  • Optimized inventory and equipment management improved reliability and operational readiness.

By implementing L7|ESP, Cellipont moved beyond regulatory compliance to pioneer a smarter, more adaptable approach to manufacturing, designed for the next era of cell therapy. Want to see how Cellipont made the leap into fully digitalized manufacturing? Download the case study here.

ABOUT THE AUTHOR

Oana Lungu, Product Manager

Oana Lungu is a product leader at L7 Informatics, combining a unique blend of scientific expertise and product management acumen to drive life sciences digital transformation strategy. Her extensive experience working with stakeholders, scientists, and technologists provided her with a deep understanding of the challenges in streamlining complex scientific workflows into scalable, data-driven digital solutions. Through strategic innovation, customer engagement, and thought leadership, she bridges science, technology, and business impact, shaping the future of scientific software. Oana holds a Ph.D. in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill.